Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083

Clinical trial NCT00722540 · COMPLETED

Trial details

NCT number: NCT00722540
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Growth Hormone Disorder Healthy

Start date: 2008-07-01
Primary completion: 2009-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.